Latest Articles
A global study linked IUDs to increased risk of breast cancer. Experts have moved to ease fears - 9News
A global study linked IUDs to increased risk of breast cancer. Experts have moved to ease fears 9News
Published: Oct. 25, 2024, 12:30 a.m.
Hollyoaks star shares how she copes with painful illness while filming - MSN
Hollyoaks star shares how she copes with painful illness while filming MSN
Published: Oct. 24, 2024, 9:50 p.m.
Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma
Hope Medicine touts favourable mid-stage data for endometriosis therapy FirstWord Pharma
Published: Oct. 24, 2024, 9:31 p.m.
Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn
Racial disparities in high-risk endometrial subtype diagnoses reported Contemporary Obgyn
Published: Oct. 24, 2024, 6:26 p.m.
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive
Published: Oct. 24, 2024, 3:55 p.m.
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer Medscape
Published: Oct. 24, 2024, 1:44 p.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace
Published: Oct. 24, 2024, 11:46 a.m.
Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com
Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com
Published: Oct. 24, 2024, 10:45 a.m.
‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? - Medscape
‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? Medscape
Published: Oct. 24, 2024, 9:51 a.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace
Published: Oct. 24, 2024, 5:36 a.m.
Link copied to clipboard!